Posted BY: Teresa | NwoReport
Amid the resurgence of COVID-19 cases and an intensified vaccination campaign, questions have arisen concerning the suspension of a key system used for reporting adverse incidents related to coronavirus vaccines. The Centers for Disease Control and Prevention (CDC) has announced a renewed emphasis on vaccinations in the upcoming months, citing the ongoing changes in the virus and the need to counter waning immunity.
The emergence of the BA.2.86 variant, capable of evading existing immunity, has heightened concerns. However, a significant reporting system for adverse reactions to vaccines has been deactivated. This system, known as V-safe, was specifically developed for COVID-19 vaccines and has played a vital role in monitoring vaccine safety throughout the pandemic.
Trending: Mugshot of Donald Trump
The CDC confirmed the discontinuation of enrollment for V-safe on May 19, 2023. A new version of the app is under development, which will accommodate reporting experiences with new vaccines. Despite this change, the CDC asserts its commitment to monitoring vaccine safety through alternate systems such as the Vaccine Adverse Event Reporting System (VAERS), operated by the Food and Drug Administration.
Critics, including David Gortler of the Brownstone Institute, have raised concerns over the sudden termination of V-safe’s adverse event reporting. They question the CDC’s rationale for ending data collection, speculating that it could undermine public health interests. Megan Redshaw, in a Substack article, expressed apprehension over the shift, highlighting the inconvenience and complexity of alternative reporting methods compared to the user-friendly V-safe.
The decision to halt a well-established reporting system has sparked skepticism and speculation about potential motives. As the vaccination drive continues, some voices within the public health discourse are urging transparency and accountability in the decisions made regarding adverse event monitoring. Concerns revolve around the perceived alignment of such actions with the narrative of vaccine safety and effectiveness.
